Implantable heart pumps reversed end-stage heart failure in 10 patients, surgeon reports.A world-renowned heart transplant surgeon announced he has successfully treated 10 patients with end-stage heart failure End-stage heart failure Severe heart disease that does not respond adequately to medical or surgical treatment. Mentioned in: Heart Transplantation with implantable heart pumps. Sir Magdi Yacoub, MD, told participants at the annual meeting of the European Society of Cardiology The European Society of Cardiology (ESC) represents more than 50,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the impact of cardiovascular disease in Europe. that the implantable pumps, HeartMate (Thoratec, Inc., Pleasanton, CA), allowed the heart to rest while drugs repaired the damaged organ. Yacoub said their hearts had been functioning normally for 1 year, with one patient reaching 4 years. Cardiologists attending the meeting took a cautious approach to the findings. Mark Entman, scientific director of the DeBakey Heart Center at the Baylor College of Medicine Baylor College of Medicine is a private medical school located in Houston, Texas, USA on the grounds of the Texas Medical Center. It has been consistently rated the top medical school in Texas and among the best in the United States. in Houston, said he sees the technique as an opportunity to regress REGRESS. Returning; going back opposed to ingress. (q.v.) heart damage over a few years. "It's unlikely that you will have large groups of these people where you will say, 'Go. Be well. You are cured.' Entman said, according to the Associated Press. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion